The Procter & Gamble Company
PG · NYSE
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2022 FY | 80.19B | 38.03B | 17.81B | 14.74B | 6.00 |
| 2023 FY | 82.01B | 39.25B | 18.13B | 14.65B | 6.07 |
| 2024 FY | 84.04B | 43.19B | 18.55B | 14.88B | 6.18 |
| 2025 FY | 84.28B | 43.12B | 20.45B | 15.97B | 6.67 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2022 FY | 117.21B | 70.35B | 7.21B | 32.29B | 46.59B |
| 2023 FY | 120.83B | 73.76B | 8.25B | 35.42B | 46.78B |
| 2024 FY | 122.37B | 71.81B | 9.48B | 33.37B | 50.29B |
| 2025 FY | 125.23B | 72.95B | 9.56B | 35.46B | 52.01B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2022 FY | 16.72B | -3.16B | 13.57B | -8.77B | -3.07B |
| 2023 FY | 16.85B | -3.06B | 13.79B | -9.00B | 1.03B |
| 2024 FY | 19.85B | -3.32B | 16.52B | -9.31B | 1.24B |
| 2025 FY | 17.82B | -3.77B | 14.04B | -9.87B | 74.00M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2022 FY | 353.29B | 378.37B | — | — | — |
| 2023 FY | 359.35B | 386.53B | — | — | — |
| 2024 FY | 384.04B | 407.92B | — | — | — |
| 2025 FY | 391.04B | 416.94B | — | — | — |
| 2026-06-30 | — | — | — | — | — |
| 2027-06-30 | — | — | — | — | — |
| 2028-06-30 | — | — | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 Q4 | 20.89B | 10.26B | 4.36B | 3.62B | 1.51 |
| 2026 Q1 | 22.39B | 11.50B | 5.86B | 4.75B | 2.00 |
| 2026 Q2 | 22.21B | 11.37B | 5.37B | 4.33B | 1.82 |
| 2026 Q3 | 21.24B | 10.51B | 4.58B | 3.97B | 1.66 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2025 Q4 | 125.23B | 72.95B | 9.56B | 35.46B | 52.01B |
| 2026 Q1 | 127.60B | 74.05B | 11.17B | 35.95B | 53.27B |
| 2026 Q2 | 127.29B | 73.97B | 10.83B | 36.64B | 53.04B |
| 2026 Q3 | 128.38B | 73.65B | 12.31B | 37.03B | 54.51B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2025 Q4 | 4.99B | -996.00M | 3.99B | -2.55B | 440.00M |
| 2026 Q1 | 5.41B | -1.20B | 4.21B | -2.55B | 1.62B |
| 2026 Q2 | 4.97B | -1.17B | 3.81B | -2.54B | -346.00M |
| 2026 Q3 | 4.05B | -1.02B | 3.03B | -2.53B | 1.48B |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2025 Q4 | 391.04B | 416.94B | — | — | — |
| 2026 Q1 | 374.41B | 399.19B | — | — | — |
| 2026 Q2 | 347.38B | 373.20B | — | — | — |
| 2026 Q3 | 349.04B | 373.76B | — | — | — |
| 2026-06-30 | — | — | — | — | — |
| 2026-09-30 | — | — | — | — | — |
| 2026-12-31 | — | — | — | — | — |